DraftKings The ‘King Of The Beat & Raise’: 7 Analysts Size Up Q1 Earnings, Raised Guidance That Could Be Conservative
DraftKings' first quarter beat and raised full year guidance. Analysts react to the report and highlight improving metrics.
Genomics firm Twist Bioscience’s Momentum To Continue Throughout 2024, Analyst Says
Twist Bioscience reports strong Q2 earnings, with sales up 25% YoY to $75.3M and orders increasing by 45%. Gross margin expands to 41%. Fiscal year guidance was raised, and William Blair sees continued growth momentum. Analysts reaffirm Outperform ratings.
Expedia Faces Challenges: Analysts Concerned About Vrbo’s Slow Start and B2C Growth
Benchmark analyst reiterated Buy rating and $180 price target for Expedia. Lowered guidance for slower growth and increased marketing spend.
7 Apple Analysts Size Up Q2 Results: Artificial Intelligence ‘A Major Upgrade Cycle Within Product Categories Such As The iPhone’
Analysts point to the strength of Apple's Services segment in the Q2. Analysts are mixed on iPhone results in China and the AI efforts from the company.
Booking Holdings Issues Soft Guidance Despite Strong Q1 Upside; These Analysts Delve Deeper
Shares of Booking Holdings Inc (NASDAQ:BKNG), the parent company of Booking.com, were climbing in early trading on Friday,…
Block Reports Blockbuster Results, Raises Guidance: Analysts Talk Square, Cash App, More
Block shares up on upbeat Q1 results amid exciting earnings season. Analysts maintain Buy and Outperform ratings with price targets up to $106.
Eye Disease-Focused Glaukos’ ‘Investor Interest Should Continue To Gain Momentum:’ Analyst
Glaukos reports Q1 adjusted EPS loss, sales beat estimates. Strong guidance for 2024 with positive analyst sentiment, driving stock up 6.22%.
Pfizer Prospects Garner Mixed Sentiment From Analysts: ‘Finally, The Pivot Investors Have Been Waiting For’
Pfizer analysts from Goldman see a positive outlook on Padcev, Prevnar, and Vindaqel, but Nurtec and Oxbryta execution needs work.
Carvana’s Strong Q1 Performance Attracts Analysts Praise, Stock Soars
Carvana shares are jumping today following yesterday's first-quarter FY24 results. Several analysts raised the price target on the stock.
How Mastercard’s Q1 Results Compare With Rival Visa: 3 Analysts Provide Their Takes
Mastercard's Q1 results fell short of expectations, causing stock pressure. Analysts give buy ratings and lowered price targets for future growth.